|
|
|
Insider
Information: |
Wheeler Kurt |
Relationship: |
10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
8,638,466 |
|
Indirect Shares
|
50,230,112 |
|
|
Direct
Value |
$53,689,639 |
|
|
Indirect Value
|
$221,891,936 |
|
|
Total
Shares |
58,868,578 |
|
|
Total
Value |
$275,581,574 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
6
|
Stock
price went up :
|
1
|
6
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
1.0
|
6.0
|
Percentage
Gain/Loss : |
12.5%
|
44.4%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Rigel Pharmaceuticals Inc |
RIGL |
10% Owner |
2003-06-26 |
3,612,947 |
2004-09-13 |
475,026 |
Premium* |
|
Cyclacel Pharmaceuticals Inc |
CYCC |
10% Owner |
|
0 |
2004-03-16 |
87,899 |
Premium* |
|
Hemosense Inc |
HEM |
Director, 10% Owner |
2005-07-01 |
0 |
2007-11-06 |
0 |
Premium* |
|
American Cryostem Corporation |
CRYO |
Director, 10% Owner |
2005-07-13 |
0 |
2008-05-28 |
0 |
Premium* |
|
Somaxon Pharmaceuticals, Inc. |
SOMX |
Director, 10% Owner |
2009-12-31 |
57,377 |
2009-12-31 |
4,632,562 |
Premium* |
|
Poniard Pharmaceuticals |
PARD |
10% Owner |
|
0 |
2009-11-09 |
6,363,249 |
Premium* |
|
Affymax Inc |
AFFY |
10% Owner |
|
0 |
2006-12-20 |
1,600,469 |
Premium* |
|
Helicos Biosciences Corp |
HLCSQ |
10% Owner |
2007-05-30 |
0 |
2007-05-30 |
2,987,769 |
Premium* |
|
Ithaka Acquisition Corp |
ITHKU |
Director, 10% Owner |
|
0 |
2007-06-21 |
2,672,568 |
Premium* |
|
Aryx Therapeutics Inc |
ARYX |
10% Owner |
2007-11-13 |
0 |
2008-11-14 |
5,364,572 |
Premium* |
|
Epirus Biopharmaceuticals Inc |
EPRS |
10% Owner |
|
0 |
2011-10-27 |
11,133,961 |
Premium* |
|
Aveo Pharmaceuticals Inc |
AVEO |
Former 10% Stockholder |
2010-03-17 |
0 |
2010-03-17 |
2,208,961 |
Premium* |
|
Zogenix, Inc. |
ZGNX |
Director, 10% Owner |
2010-11-29 |
0 |
2010-11-29 |
5,982,439 |
Premium* |
|
Humanigen Inc |
HGEN |
10% Owner |
2013-02-05 |
0 |
2013-02-05 |
2,632,928 |
Premium* |
|
Aerie Pharmaceuticals Inc |
AERI |
10% Owner |
2015-01-28 |
0 |
2013-10-25 |
0 |
Premium* |
|
Oxford Immunotec Global Plc |
OXFD |
10% Owner |
2015-06-16 |
2,237,377 |
2013-11-22 |
0 |
Premium* |
|
Radius Health Inc. |
RDUS |
Former 10% stockholder |
2014-06-06 |
0 |
2016-09-27 |
2,459,804 |
Premium* |
|
Iveric Bio Inc |
ISEE |
10% Owner |
2015-05-26 |
0 |
2014-06-11 |
4,500 |
Premium* |
|
Sientra, Inc. |
SIEN |
10% Owner |
2014-10-28 |
2,730,765 |
|
0 |
Premium* |
|
Entasis Therapeutics Holdings Inc. |
ETTX |
10% Owner |
2018-09-28 |
0 |
2018-09-28 |
1,623,405 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
137 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
RIGL |
Rigel Pharmaceuticals Inc |
10% Owner |
|
2003-06-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,612,947 |
|
- |
|
RIGL |
Rigel Pharmaceuticals Inc |
10% Owner |
|
2003-06-26 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
900,942 |
|
- |
|
CYCC |
Cyclacel Pharmaceuticals ... |
10% Owner |
|
2004-03-10 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
87,899 |
|
- |
|
CYCC |
Cyclacel Pharmaceuticals ... |
10% Owner |
|
2004-03-16 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
87,899 |
|
- |
|
PARD |
Poniard Pharmaceuticals |
10% Owner |
|
2006-04-26 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
35,749,286 |
|
- |
|
AFFY |
Affymax Inc |
10% Owner |
|
2006-12-14 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
31,248 |
|
- |
|
ITHKU |
Ithaka Acquisition Corp |
Director |
|
2007-06-21 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,672,568 |
|
- |
|
EPRS |
Epirus Biopharmaceuticals... |
10% Owner |
|
2009-12-21 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
22,547,613 |
|
- |
|
SIEN |
Sientra, Inc. |
10% Owner |
|
2014-10-28 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,730,765 |
|
- |
|
AERI |
Aerie Pharmaceuticals Inc |
10% Owner |
|
2014-12-23 |
4 |
S |
$30.00 |
$7,890 |
D/D |
(263) |
3,603,603 |
0 |
- |
|
RIGL |
Rigel Pharmaceuticals Inc |
10% Owner |
|
2004-06-23 |
4 |
S |
$15.50 |
$6,014 |
I/I |
(388) |
3,460,770 |
|
- |
|
RIGL |
Rigel Pharmaceuticals Inc |
10% Owner |
|
2004-04-12 |
4 |
S |
$19.80 |
$7,920 |
I/I |
(400) |
3,834,269 |
|
- |
|
ISEE |
Iveric Bio Inc |
10% Owner |
|
2014-06-11 |
4 |
S |
$44.32 |
$22,160 |
I/I |
(500) |
4,500 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2008-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
543 |
543 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2007-05-02 |
4 |
AS |
$18.03 |
$12,170 |
I/I |
(675) |
3,432,669 |
0 |
- |
|
RIGL |
Rigel Pharmaceuticals Inc |
10% Owner |
|
2004-08-25 |
4 |
S |
$19.77 |
$16,330 |
I/I |
(826) |
1,772,099 |
|
- |
|
OXFD |
Oxford Immunotec Global P... |
10% Owner |
|
2015-06-15 |
4 |
S |
$14.27 |
$21,819 |
D/D |
(1,529) |
2,277,078 |
0 |
- |
|
RIGL |
Rigel Pharmaceuticals Inc |
10% Owner |
|
2004-06-02 |
4 |
S |
$18.00 |
$36,540 |
I/I |
(2,030) |
3,490,963 |
|
- |
|
OXFD |
Oxford Immunotec Global P... |
10% Owner |
|
2015-06-08 |
4 |
S |
$14.25 |
$37,934 |
D/D |
(2,662) |
2,332,192 |
0 |
- |
|
RIGL |
Rigel Pharmaceuticals Inc |
10% Owner |
|
2004-06-28 |
4 |
S |
$15.83 |
$45,545 |
I/I |
(2,877) |
3,333,586 |
|
- |
|
RIGL |
Rigel Pharmaceuticals Inc |
10% Owner |
|
2004-05-24 |
4 |
S |
$17.35 |
$57,255 |
I/I |
(3,300) |
3,532,958 |
|
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2007-05-04 |
4 |
AS |
$18.00 |
$68,400 |
I/I |
(3,800) |
3,428,869 |
0 |
- |
|
RIGL |
Rigel Pharmaceuticals Inc |
10% Owner |
|
2004-05-28 |
4 |
S |
$18.00 |
$71,100 |
I/I |
(3,950) |
3,502,993 |
|
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2009-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
4,359 |
48,002 |
0 |
- |
|
RIGL |
Rigel Pharmaceuticals Inc |
10% Owner |
|
2004-08-19 |
4 |
S |
$21.77 |
$108,847 |
I/I |
(5,000) |
1,800,424 |
|
- |
|
137 Records found
|
|
Page 1 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|